Structural Bioinformatics of the Human Spliceosomal Proteome Iga Korneta1, Marcin Magnus1 and Janusz M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genome-Wide Parent-Of-Origin DNA Methylation Analysis Reveals The
Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Research Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment Franck Court,1,15 Chiharu Tayama,2,15 Valeria Romanelli,1,15 Alex Martin-Trujillo,1,15 Isabel Iglesias-Platas,3 Kohji Okamura,4 Naoko Sugahara,2 Carlos Simo´n,5 Harry Moore,6 Julie V. Harness,7 Hans Keirstead,7 Jose Vicente Sanchez-Mut,8 Eisuke Kaneki,9 Pablo Lapunzina,10 Hidenobu Soejima,11 Norio Wake,9 Manel Esteller,8,12,13 Tsutomu Ogata,14 Kenichiro Hata,2 Kazuhiko Nakabayashi,2,16,17 and David Monk1,16,17 1–14[Author affiliations appear at the end of the paper.] Differential methylation between the two alleles of a gene has been observed in imprinted regions, where the methylation of one allele occurs on a parent-of-origin basis, the inactive X-chromosome in females, and at those loci whose methylation is driven by genetic variants. We have extensively characterized imprinted methylation in a substantial range of normal human tissues, reciprocal genome-wide uniparental disomies, and hydatidiform moles, using a combination of whole- genome bisulfite sequencing and high-density methylation microarrays. This approach allowed us to define methylation profiles at known imprinted domains at base-pair resolution, as well as to identify 21 novel loci harboring parent-of-origin methylation, 15 of which are restricted to the placenta. We observe that the extent of imprinted differentially methylated regions (DMRs) is extremely similar between tissues, with the exception of the placenta. -
Lineage-Specific Programming Target Genes Defines Potential for Th1 Temporal Induction Pattern of STAT4
Downloaded from http://www.jimmunol.org/ by guest on October 1, 2021 is online at: average * The Journal of Immunology published online 26 August 2009 from submission to initial decision 4 weeks from acceptance to publication J Immunol http://www.jimmunol.org/content/early/2009/08/26/jimmuno l.0901411 Temporal Induction Pattern of STAT4 Target Genes Defines Potential for Th1 Lineage-Specific Programming Seth R. Good, Vivian T. Thieu, Anubhav N. Mathur, Qing Yu, Gretta L. Stritesky, Norman Yeh, John T. O'Malley, Narayanan B. Perumal and Mark H. Kaplan Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/suppl/2009/08/26/jimmunol.090141 1.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* • Why • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 1, 2021. Published August 26, 2009, doi:10.4049/jimmunol.0901411 The Journal of Immunology Temporal Induction Pattern of STAT4 Target Genes Defines Potential for Th1 Lineage-Specific Programming1 Seth R. Good,2* Vivian T. Thieu,2† Anubhav N. Mathur,† Qing Yu,† Gretta L. -
Genetic Variants and Prostate Cancer Risk: Candidate Replication and Exploration of Viral Restriction Genes
2137 Genetic Variants and Prostate Cancer Risk: Candidate Replication and Exploration of Viral Restriction Genes Joan P. Breyer,1 Kate M. McReynolds,1 Brian L. Yaspan,2 Kevin M. Bradley,1 William D. Dupont,3 and Jeffrey R. Smith1,2,4 Departments of 1Medicine, 2Cancer Biology, and 3Biostatistics, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine; and 4Medical Research Service, VA Tennessee Valley Healthcare System, Nashville, Tennessee Abstract The genetic variants underlying the strong heritable at genome-wide association study loci 8q24, 11q13, and À À component ofprostate cancer remain largely unknown. 2p15 (P =2.9Â 10 4 to P =4.7Â 10 5), showing study Genome-wide association studies ofprostate cancer population power. We also find evidence to support have yielded several variants that have significantly reported associations at candidate genes RNASEL, replicated across studies, predominantly in cases EZH2, and NKX3-1 (P = 0.031 to P = 0.0085). We unselected for family history of prostate cancer. further explore a set of candidate genes related to Additional candidate gene variants have also been RNASEL and to its role in retroviral restriction, proposed, many evaluated within familial prostate identifying nominal associations at XPR1 and RBM9. cancer study populations. Such variants hold great The effects at 8q24 seem more pronounced for those potential value for risk stratification, particularly for diagnosed at an early age, whereas at 2p15 and early-onset or aggressive prostate cancer, given the RNASEL the effects were more pronounced at a later comorbidities associated with current therapies. Here, age. However, these trends did not reach statistical we investigate a Caucasian study population of523 significance. -
Analysis of Alternative Splicing Associated with Aging and Neurodegeneration in the Human Brain
Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Research Analysis of alternative splicing associated with aging and neurodegeneration in the human brain James R. Tollervey,1 Zhen Wang,1 Tibor Hortoba´gyi,2 Joshua T. Witten,1 Kathi Zarnack,3 Melis Kayikci,1 Tyson A. Clark,4 Anthony C. Schweitzer,4 Gregor Rot,5 Tomazˇ Curk,5 Blazˇ Zupan,5 Boris Rogelj,2 Christopher E. Shaw,2 and Jernej Ule1,6 1MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom; 2MRC Centre for Neurodegeneration Research, King’s College London, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, United Kingdom; 3EMBL–European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom; 4Expression Research, Affymetrix, Inc., Santa Clara, California 95051, USA; 5Faculty of Computer and Information Science, University of Ljubljana, Trzˇasˇka 25, SI-1000 Ljubljana, Slovenia Age is the most important risk factor for neurodegeneration; however, the effects of aging and neurodegeneration on gene expression in the human brain have most often been studied separately. Here, we analyzed changes in transcript levels and alternative splicing in the temporal cortex of individuals of different ages who were cognitively normal, affected by frontotemporal lobar degeneration (FTLD), or affected by Alzheimer’s disease (AD). We identified age-related splicing changes in cognitively normal individuals and found that these were present also in 95% of individuals with FTLD or AD, independent of their age. These changes were consistent with increased polypyrimidine tract binding protein (PTB)– dependent splicing activity. We also identified disease-specific splicing changes that were present in individuals with FTLD or AD, but not in cognitively normal individuals. -
Dual Function of C/D Box Small Nucleolar Rnas in Rrna PNAS PLUS Modification and Alternative Pre-Mrna Splicing
Dual function of C/D box small nucleolar RNAs in rRNA PNAS PLUS modification and alternative pre-mRNA splicing Marina Falaleevaa, Amadis Pagesb, Zaneta Matuszeka, Sana Hidmic, Lily Agranat-Tamirc, Konstantin Korotkova, Yuval Nevod, Eduardo Eyrasb,e, Ruth Sperlingc, and Stefan Stamma,1 aDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536; bDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, E08003 Barcelona, Spain; cDepartment of Genetics, Hebrew University of Jerusalem, 91904 Jerusalem, Israel; dDepartment of Microbiology and Molecular Genetics, Computation Center at the Hebrew University and Hadassah Medical Center, 91904 Jerusalem, Israel; and eCatalan Institution for Research and Advanced Studies, E08010 Barcelona, Spain Edited by James E. Dahlberg, University of Wisconsin Medical School, Madison, WI, and approved February 5, 2016 (received for review October 1, 2015) C/D box small nucleolar RNAs (SNORDs) are small noncoding RNAs, SNORD fragments are not microRNAs, which have an average and their best-understood function is to target the methyltrans- length of 21–22 nt (13–16), and suggests that these fragments may ferase fibrillarin to rRNA (for example, SNORD27 performs 2′-O- have additional functions. methylation of A27 in 18S rRNA). Unexpectedly, we found a subset The association of some SNORDs with specific diseases sug- of SNORDs, including SNORD27, in soluble nuclear extract made gests that they may possess functions in addition to directing the under native conditions, where fibrillarin was not detected, indi- 2′-O-methylation of rRNA. For example, the loss of SNORD116 cating that a fraction of the SNORD27 RNA likely forms a protein expression is a decisive factor in Prader–Willi syndrome, the most complex different from canonical snoRNAs found in the insoluble common genetic cause for hyperphagia and obesity (17, 18). -
Mutational Screening of Splicing Factor Genes in Cases with Autosomal Dominant Retinitis Pigmentosa
Mutational screening of splicing factor genes in cases with autosomal dominant retinitis pigmentosa The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Benaglio, Paola, Patricia Fernandez San Jose, Almudena Avila- Fernandez, Giulia Ascari, Shyana Harper, Gaël Manes, Carmen Ayuso, Christian Hamel, Eliot L. Berson, and Carlo Rivolta. 2014. “Mutational screening of splicing factor genes in cases with autosomal dominant retinitis pigmentosa.” Molecular Vision 20 (1): 843-851. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406726 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Molecular Vision 2014; 20:843-851 <http://www.molvis.org/molvis/v20/843> © 2014 Molecular Vision Received 27 January 2014 | Accepted 16 June 2014 | Published 18 June 2014 Mutational screening of splicing factor genes in cases with autosomal dominant retinitis pigmentosa Paola Benaglio,1 Patricia Fernandez San Jose,2,3 Almudena Avila-Fernandez,2,3 Giulia Ascari,1 Shyana Harper,4 Gaël Manes,5 Carmen Ayuso,2,3 Christian Hamel,5 Eliot L. Berson,4 Carlo Rivolta1 1Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland; 2Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain; 3Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain; 4The Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA; 5INSERM U1051, Institut des Neurosciences de Montpellier, Hôpital Saint Eloi, Montpellier, France Purpose: Mutations in genes encoding proteins from the tri-snRNP complex of the spliceosome account for more than 12% of cases of autosomal dominant retinitis pigmentosa (adRP). -
Genequery™ Human Cdna Evaluation Kit, Deluxe (GQH-CED) Catalog #GK991 100 Reactions
GeneQuery™ Human cDNA Evaluation Kit, Deluxe (GQH-CED) Catalog #GK991 100 reactions Product Description ScienCell's GeneQuery™ Human cDNA Evaluation Kit, Deluxe (GQH-CED) assesses cDNA quality. The kit verifies successful reverse transcription of messenger RNA (mRNA) to complementary DNA (cDNA), reveals the presence of genomic DNA (gDNA) contamination in cDNA samples, and detects qPCR inhibitor contamination. Good quality cDNA is a critical component for successful gene expression profiling. The GQH-CED kit is highly recommended for cDNA applications such as GeneQuery™ qPCR arrays. Each primer set included in GQH-CED qPCR kit arrives lyophilized in a 2 mL vial. All primers are designed and tested under the same parameters: (i) an optimal annealing temperature of 65°C (with 2 mM Mg 2+ , and no DMSO); (ii) recognition of all known target gene transcript variants; and (iii) specific amplification of only one amplicon. Each primer set has been validated by qPCR by melt curve analysis and gel electrophoresis. GeneQuery™ Human cDNA Evaluation Kit, Deluxe Components Cat. No. Quantity Component Amplicon size Human LDHA cDNA primer set GK991a 1 vial 130 bp (lyophilized, 100 reactions) Human PPIH cDNA primer set GK991b 1 vial 149 bp (lyophilized, 100 reactions) Human genomic DNA Control (GDC) primer set GK991c 1 vial 81 bp (lyophilized, 100 reactions) Positive PCR Control (PPC) primer set GK991d 1 vial 147 bp (lyophilized, 100 reactions) GK991e 8 mL Nuclease-free H 2O N/A • LDHA cDNA primer set targets housekeeping gene LDHA. The forward and reverse primers are located on different exons, giving variant amplicon sizes for cDNA and gDNA. -
A Portable BRCA1-HAC (Human Artificial Chromosome) Module For
Published online 26 September 2014 Nucleic Acids Research, 2014, Vol. 42, No. 21 e164 doi: 10.1093/nar/gku870 A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor function Artem V. Kononenko1, Ruchi Bansal2, Nicholas C.O. Lee1, Brenda R. Grimes2, Hiroshi Masumoto3, William C. Earnshaw4, Vladimir Larionov1 and Natalay Kouprina1,* 1Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA, 2Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA, 3Laboratory of Cell Engineering, Department of Frontier Research, Kazusa DNA, Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu, Chiba 292-0818, Japan and 4Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3JR, Scotland Downloaded from Received August 04, 2014; Revised September 03, 2014; Accepted September 10, 2014 ABSTRACT INTRODUCTION http://nar.oxfordjournals.org/ BRCA1 is involved in many disparate cellular func- BRCA1 is a well-known tumor suppressor gene, germ line tions, including DNA damage repair, cell-cycle check- mutations in which predispose women to breast and ovarian point activation, gene transcriptional regulation, cancers. Since the identification of the BRCA1 gene, there DNA replication, centrosome function and others. have been numerous studies aimed at characterizing the di- The majority of evidence strongly favors the mainte- verse repertoire of its biological functions. BRCA1 is in- volved in multiple cellular pathways, including DNA dam- nance of genomic integrity as a principal tumor sup- age repair, chromatin remodeling, X-chromosome inactiva- pressor activity of BRCA1. At the same time some tion, centrosome duplication and cell-cycle regulation (1– at Ruth Lilly Medical Library on March 18, 2016 functional aspects of BRCA1 are not fully under- 7). -
Molecular Processes During Fat Cell Development Revealed by Gene
Open Access Research2005HackletVolume al. 6, Issue 13, Article R108 Molecular processes during fat cell development revealed by gene comment expression profiling and functional annotation Hubert Hackl¤*, Thomas Rainer Burkard¤*†, Alexander Sturn*, Renee Rubio‡, Alexander Schleiffer†, Sun Tian†, John Quackenbush‡, Frank Eisenhaber† and Zlatko Trajanoski* * Addresses: Institute for Genomics and Bioinformatics and Christian Doppler Laboratory for Genomics and Bioinformatics, Graz University of reviews Technology, Petersgasse 14, 8010 Graz, Austria. †Research Institute of Molecular Pathology, Dr Bohr-Gasse 7, 1030 Vienna, Austria. ‡Dana- Farber Cancer Institute, Department of Biostatistics and Computational Biology, 44 Binney Street, Boston, MA 02115. ¤ These authors contributed equally to this work. Correspondence: Zlatko Trajanoski. E-mail: [email protected] Published: 19 December 2005 Received: 21 July 2005 reports Revised: 23 August 2005 Genome Biology 2005, 6:R108 (doi:10.1186/gb-2005-6-13-r108) Accepted: 8 November 2005 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2005/6/13/R108 © 2005 Hackl et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which deposited research permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Gene-expression<p>In-depthadipocytecell development.</p> cells bioinformatics were during combined fat-cell analyses with development de of novo expressed functional sequence annotation tags fo andund mapping to be differentially onto known expres pathwayssed during to generate differentiation a molecular of 3 atlasT3-L1 of pre- fat- Abstract Background: Large-scale transcription profiling of cell models and model organisms can identify novel molecular components involved in fat cell development. -
Compound Heterozygous Mutations in the Noncoding RNU4ATAC Cause Roifman Syndrome by Disrupting Minor Intron Splicing
ARTICLE Received 2 Feb 2015 | Accepted 25 Sep 2015 | Published 2 Nov 2015 DOI: 10.1038/ncomms9718 OPEN Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing Daniele Merico1,*, Maian Roifman2,3,4,*, Ulrich Braunschweig5,RyanK.C.Yuen1, Roumiana Alexandrova1, Andrea Bates6, Brenda Reid6, Thomas Nalpathamkalam1,ZhuozhiWang1, Bhooma Thiruvahindrapuram1, Paul Gray7, Alyson Kakakios8, Jane Peake9,10, Stephanie Hogarth9,10,DavidManson11, Raymond Buncic12, Sergio L. Pereira1, Jo-Anne Herbrick1,BenjaminJ.Blencowe5,13,ChaimM.Roifman4,6 &StephenW.Scherer1,13,14,15 Roifman Syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency. Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal compound heterozygous rare variants that disrupt highly conserved positions of the RNU4ATAC small nuclear RNA gene, a minor spliceosome component that is essential for minor intron splicing. Targeted sequencing confirms allele segregation in six cases from four unrelated families. RNU4ATAC rare variants have been recently reported to cause microcephalic osteodysplastic primordial dwarfism, type I (MOPD1), whose phenotype is distinct from Roifman Syndrome. Strikingly, all six of the Roifman Syndrome cases have one variant that overlaps MOPD1-implicated structural elements, while the other variant overlaps a highly conserved structural element not previously implicated in disease. RNA-seq analysis confirms extensive and specific defects of minor intron splicing. Available allele frequency data suggest that recessive genetic disorders caused by RNU4ATAC rare variants may be more prevalent than previously reported. 1 The Centre for Applied Genomics (TCAG), Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 0A4. -
Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ...................................................... -
Epigenetic and Transcriptional Determinants of the Human Breast
ARTICLE Received 5 Nov 2014 | Accepted 22 Jan 2015 | Published 18 Feb 2015 DOI: 10.1038/ncomms7351 OPEN Epigenetic and transcriptional determinants of the human breast Philippe Gascard1,*, Misha Bilenky2,*, Mahvash Sigaroudinia1, Jianxin Zhao1, Luolan Li3, Annaick Carles3, Allen Delaney2, Angela Tam2, Baljit Kamoh2, Stephanie Cho2, Malachi Griffith2, Andy Chu2, Gordon Robertson2, Dorothy Cheung2, Irene Li2, Alireza Heravi-Moussavi2, Michelle Moksa3, Matthew Mingay3, Angela Hussainkhel3, Brad Davis2, Raman P. Nagarajan4, Chibo Hong4, Lorigail Echipare5, Henriette O’Geen5, Matthew J. Hangauer6, Jeffrey B. Cheng7, Dana Neel4, Donglei Hu8, Michael T. McManus6, Richard Moore2, Andrew Mungall2, Yussanne Ma2, Patrick Plettner2, Elad Ziv8, Ting Wang9, Peggy J. Farnham10, Steven J.M. Jones2,11, Marco A. Marra2,11, Thea D. Tlsty1, Joseph F. Costello4 & Martin Hirst2,3 While significant effort has been dedicated to the characterization of epigenetic changes associated with prenatal differentiation, relatively little is known about the epigenetic changes that accompany post-natal differentiation where fully functional differentiated cell types with limited lifespans arise. Here we sought to address this gap by generating epigenomic and transcriptional profiles from primary human breast cell types isolated from disease-free human subjects. From these data we define a comprehensive human breast transcriptional network, including a set of myoepithelial- and luminal epithelial-specific intronic retention events. Intersection of epigenetic states with RNA expression from distinct breast epithelium lineages demonstrates that mCpG provides a stable record of exonic and intronic usage, whereas H3K36me3 is dynamic. We find a striking asymmetry in epigenomic reprogramming between luminal and myoepithelial cell types, with the genomes of luminal cells harbouring more than twice the number of hypomethylated enhancer elements compared with myoepithelial cells.